Our group has developed the concept of “Karanahan technology.” This approach, similarly to those mentioned above, is of chronometric nature and implies the administration of both cyclophosphamide (CP) and the complex composite “DNAmix” preparation in strict dependence on the duration of DNA repair and the cell cycle pattern of each certain tumor. The gene discussed is CP; the disease is neoplasm.